Cargando…

Sex Differences in Time-Series Changes in Pseudo-R(2) Values Regarding Hyperuricemia in Relation to the Kidney Prognosis

Studies on sex differences in time-series changes in pseudo-R(2) values regarding hyperuricemia (HU) in relation to the kidney prognosis among patients with chronic kidney disease (CKD) are scant. The kidney prognosis was evaluated in 200 patients with CKD (median follow-up, 12.3 years). Survival an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kataoka, Hiroshi, Ohara, Mamiko, Mochizuki, Toshio, Iwadoh, Kazuhiro, Ushio, Yusuke, Kawachi, Keiko, Watanabe, Kentaro, Watanabe, Saki, Akihisa, Taro, Makabe, Shiho, Manabe, Shun, Sato, Masayo, Iwasa, Naomi, Yoshida, Rie, Sawara, Yukako, Hanafusa, Norio, Tsuchiya, Ken, Nitta, Kosaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711484/ https://www.ncbi.nlm.nih.gov/pubmed/33256045 http://dx.doi.org/10.3390/jpm10040248

Ejemplares similares

Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney disease
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes
por: Manabe, Shun, et al.
Publicado: (2021)

Maximum Glomerular Diameter and Oxford MEST-C Score in IgA Nephropathy: The Significance of Time-Series Changes in Pseudo-R(2) Values in Relation to Renal Outcomes
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

Machine learning for morbid glomerular hypertrophy
por: Ushio, Yusuke, et al.
Publicado: (2022)

High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study
por: Sato, Masayo, et al.
Publicado: (2020)

Time series changes in pseudo-R(2) values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Germline Mutations for Kidney Volume in ADPKD
por: Kataoka, Hiroshi, et al.
Publicado: (2021)

Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
por: Kataoka, Hiroshi, et al.
Publicado: (2022)

Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD
por: Makabe, Shiho, et al.
Publicado: (2021)

Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study
por: Kataoka, Hiroshi, et al.
Publicado: (2022)

Impacts of Sex Differences in Pulse Pressure among Patients with Chronic Kidney Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease
por: Aoyama, Yumi, et al.
Publicado: (2020)

Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Required Surgical Treatment
por: Watanabe, Kentaro, et al.
Publicado: (2018)

Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis: A case report
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

PKD1 mutation may epistatically ameliorate nephronophthisis progression in patients with NPHP1 deletion
por: Watanabe, Saki, et al.
Publicado: (2019)

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
por: Tsuruta, Yuki, et al.
Publicado: (2014)

Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome
por: Akihisa, Taro, et al.
Publicado: (2019)

Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to rituximab therapy between childhood-onset and adult-onset disease
por: Iwabuchi, Yuko, et al.
Publicado: (2018)

Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis
por: Momoki, Kumiko, et al.
Publicado: (2017)

Proximal Tubulopathy With Fibrillary Inclusions: A Rare Manifestation of Lymphoma-Associated Monoclonal Gammopathy of Renal Significance (MGRS)
por: Ino, Ayami, et al.
Publicado: (2019)

Preoperative assessment system for hand-assisted laparoscopic donor nephrectomy by discriminant analysis
por: Iwadoh, Kazuhiro, et al.
Publicado: (2020)

Effects of tolvaptan on renal function in chronic kidney disease patients with volume overload
por: Suzuki, Shunji, et al.
Publicado: (2018)

Denosumab Recovers Aortic Arch Calcification During Long-Term Hemodialysis
por: Suzuki, Shunji, et al.
Publicado: (2020)

Lupus Nephritis and Hydroxychloroquine-Associated Zebra Bodies: Not Just in Fabry Disease
por: Manabe, Shun, et al.
Publicado: (2021)

Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy: Importance of Type IV Collagen Staining
por: Sato, Masayo, et al.
Publicado: (2021)

Biopsy-proven vancomycin-induced acute kidney injury: a case report and literature review
por: Sawada, Anri, et al.
Publicado: (2018)

Clinical Significance of Elevated Xanthine Dehydrogenase Levels and Hyperuricemia in Patients with Sepsis
por: Matsuoka, Masaru, et al.
Publicado: (2023)

Inhibition of T cell-mediated inflammation in uveitis by a novel anti-CD3 antibody
por: Sugita, Sunao, et al.
Publicado: (2017)

Management of Osteoporosis in Chronic Kidney Disease
por: Nitta, Kosaku, et al.
Publicado: (2017)

Serum Hepcidin Levels and Reticulocyte Hemoglobin Concentrations as Indicators of the Iron Status of Peritoneal Dialysis Patients
por: Eguchi, Aya, et al.
Publicado: (2012)

Influence of hyperuricemia treatment on postoperative acute kidney injury among hyperuricemia patients: a single-center retrospective database analysis
por: Watanabe, Shinichiro, et al.
Publicado: (2019)

Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
por: Akimoto, Tetsu, et al.
Publicado: (2014)

Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
por: Usui, Ryosuke, et al.
Publicado: (2018)

Long-term effects of contrast media exposure on renal failure progression: a retrospective cohort study
por: Takura, Tomoyuki, et al.
Publicado: (2023)

Variation of Urate Transport in the Nephrons in Subtypes of Hyperuricemia
por: Nakamura, Toru, et al.
Publicado: (2013)

Multiplatform metabolomic analysis of the R6/2 mouse model of Huntington’s disease
por: Hashimoto, Masayo, et al.
Publicado: (2021)

Primary IgA Vasculitis with Nephritis in a Patient with Rheumatoid Arthritis Diagnosed by Anti-galactose-deficient IgA1 Immunostaining
por: Karasawa, Kazunori, et al.
Publicado: (2019)

Prospective Study of Engagement in Leisure Activities and All-Cause Mortality Among Older Japanese Adults
por: Kobayashi, Takaki, et al.
Publicado: (2022)

Risk Factors for Hyperuricemia or Gout in Men and Women: The Circulatory Risk in Communities Study (CIRCS)
por: Teramura, Saki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lcl9sd70ss9i8uo854qqtlteeh